Research Underway...
 |
Rett Syndrome is classified as a rare illness. As a result, there has been limited funding towards a cure by the National Institutes of Health (NIH). Those who were originally diagnosed with Rett Syndrome had no hope for a cure. Moreover, medication to address the symptoms were underdeveloped. After time, the list of children who had Rett Syndrome grew. It was not until the 1980s when research picked up speed and attention. Families started to have hope. As time passed, more organizations began to raise funds to drive research for both treating the symptoms and a cure. Today, we are closer to a cure than we ever have been. Families feel mixed emotions as one day their child might be able to speak, walk, and do all the other things we take for granted.
|
|
Clinical Solutions...
| Over the decades, medication has been developed to address the symptoms of Rett Syndrome. These medications have provided help to others with the same symptoms who are not diagnosed with Rett Syndrome. While medication helps bring comfort to the person, it does not address all symptoms or the underlining illness. Thus, it is important to develop new medication to prevent discomfort and further destruction. |
 |
|
Cure...
 |
Research shows a cure is reachable. It's a matter of funding and scientific research. The faster we can raise the money, the faster the scientist can finish their research. Once research is completed, it's all about human trials and delivery to the public. Once Rett Syndrome is cured, it will be easier for scientist to cure other illnesses. Think about all the developed tools, mechanisms, strategies, and delivery techniques now available due to this one illness. CURING RETT SYNDROME IS KEY. |
|
The Research That Benefits More Than One Illness...
| Due to the complexity of Rett Syndrome, the applications used to cure it can be recycled for other illnesses. Developing cures available to market takes decades, especially for the more complicated and rare diseases. Just imagine the time saved developing a cure for another illness if a previous cure provided the applications. When the Medical industry cures a rare disease, the insurance companies, plan sponsors, governments, and most importantly the families, save money. At the end of the day, the general public has mixed thoughts on how to spend taxpayer dollars on medical research. The two options are to spend lots of money upfront curing an illness or spend far less money to simply support medication to mask the discomfort. At what point does reoccurring medical costs justify the investment of a cure? |
 |
|
